A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

NCT07094204 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Non-Small-Cell Lung Cancer
Pancreatic Ductal Adenocarcinoma
Colorectal Cancer

Interventions

DRUG: ASP5834
DRUG: panitumumab

Sponsor

Astellas Pharma Inc